FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103246276> ?p ?o ?g. }

• W2103246276 endingPage "7" @default.
• W2103246276 startingPage "1" @default.
• W2103246276 abstract "Management of benign prostatic hyperplasia with silodosin Tomonori Yamanishi1, Tomoya Mizuno1, Takao Kamai1, Ken-ichiro Yoshida1, Ryuji Sakakibara2, Tomoyuki Uchiyama31Department of Urology, Dokkyo Medical University, Tochigi, Japan; 2Department of Neurology, Sakura Hospital, Toho University, Toho, Japan; 3Department of Neurology, Chiba University, Chiba, JapanAbstract: It has been reported that blockade of α1A-adrenoceptor (AR) relieves bladder outlet obstruction, while blockade of α1D-AR is believed to alleviate storage symptoms due to detrusor overactivity. Silodosin, (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2trifluoroethoxy) phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7- carboxamide, is a new α1A-AR selective antagonist. Silodosin is highly selective for the α1A-AR subtype, showing an affinity for the α1A-AR that is 583- and 55.5-fold higher than its affinity for the α1B- and α1D-ARs, respectively. In randomized, double-blind, placebo-controlled phase III studies performed in Japan and the United States, silodosin has been shown to be effective for both storage and voiding symptoms associated with benign prostatic hyperplasia. Early effects of silodosin (after 2–6 hours or day 1) on lower urinary tract symptoms have also been reported. In urodynamic studies, detrusor overactivity disappeared in 40% and improved in 35% of patients after administration. In pressure flow studies, the grade of obstruction on the International Continence Society nomogram showed improvement in 56% of patients. The rate of adverse events in the silodosin, tamsulosin and placebo groups was 88.6%, 82.3%, and 71.6%, respectively. The most common adverse event was (mostly mild) abnormal ejaculation (28.1%). However, few patients (2.8%) discontinued silodosin because of abnormal ejaculation. Orthostatic hypotension showed a similar incidence in the silodosin (2.6%) and placebo (1.5%) groups. In conclusion, silodosin improves detrusor overactivity and obstruction and thus may be effective for both storage and voiding symptoms in patients with benign prostatic hyperplasia.Keywords: alpha-blocker, silodosin, benign prostatic hyperplasia, lower urinary tract symptoms" @default.
• W2103246276 created "2016-06-24" @default.
• W2103246276 creator A5000874948 @default.
• W2103246276 creator A5005428468 @default.
• W2103246276 creator A5049505360 @default.
• W2103246276 creator A5061041464 @default.
• W2103246276 creator A5077854199 @default.
• W2103246276 creator A5083613523 @default.
• W2103246276 date "2009-08-01" @default.
• W2103246276 modified "2023-10-17" @default.
• W2103246276 title "Management of benign prostatic hyperplasia with silodosin" @default.
• W2103246276 cites W109614840 @default.
• W2103246276 cites W1489169544 @default.
• W2103246276 cites W1518923395 @default.
• W2103246276 cites W1532870926 @default.
• W2103246276 cites W1539512323 @default.
• W2103246276 cites W1575890696 @default.
• W2103246276 cites W1673517828 @default.
• W2103246276 cites W1831194115 @default.
• W2103246276 cites W1917454581 @default.
• W2103246276 cites W1918732584 @default.
• W2103246276 cites W1968924642 @default.
• W2103246276 cites W1969671428 @default.
• W2103246276 cites W1971073617 @default.
• W2103246276 cites W1971867200 @default.
• W2103246276 cites W1973435584 @default.
• W2103246276 cites W1979254549 @default.
• W2103246276 cites W1979677964 @default.
• W2103246276 cites W1982962434 @default.
• W2103246276 cites W198934061 @default.
• W2103246276 cites W1990732773 @default.
• W2103246276 cites W1991315347 @default.
• W2103246276 cites W1992790153 @default.
• W2103246276 cites W2005441479 @default.
• W2103246276 cites W2005781356 @default.
• W2103246276 cites W2008168996 @default.
• W2103246276 cites W2008616189 @default.
• W2103246276 cites W2012405024 @default.
• W2103246276 cites W2016696865 @default.
• W2103246276 cites W2020664021 @default.
• W2103246276 cites W2025350702 @default.
• W2103246276 cites W2027687642 @default.
• W2103246276 cites W2033685093 @default.
• W2103246276 cites W2033931603 @default.
• W2103246276 cites W2035539636 @default.
• W2103246276 cites W2039611380 @default.
• W2103246276 cites W2043961078 @default.
• W2103246276 cites W2044618839 @default.
• W2103246276 cites W2052649868 @default.
• W2103246276 cites W2055441966 @default.
• W2103246276 cites W2057346410 @default.
• W2103246276 cites W2058584660 @default.
• W2103246276 cites W2067176390 @default.
• W2103246276 cites W2068657179 @default.
• W2103246276 cites W2071502429 @default.
• W2103246276 cites W2073123650 @default.
• W2103246276 cites W2078602729 @default.
• W2103246276 cites W2086603860 @default.
• W2103246276 cites W2087654797 @default.
• W2103246276 cites W2087918559 @default.
• W2103246276 cites W2093140114 @default.
• W2103246276 cites W2096556143 @default.
• W2103246276 cites W2096729009 @default.
• W2103246276 cites W2098393666 @default.
• W2103246276 cites W2101665942 @default.
• W2103246276 cites W2103581840 @default.
• W2103246276 cites W2104967317 @default.
• W2103246276 cites W2108847543 @default.
• W2103246276 cites W2113557254 @default.
• W2103246276 cites W2127501670 @default.
• W2103246276 cites W2147450987 @default.
• W2103246276 cites W2153395682 @default.
• W2103246276 cites W2184332729 @default.
• W2103246276 cites W2273864730 @default.
• W2103246276 cites W2409867059 @default.
• W2103246276 cites W2440254723 @default.
• W2103246276 cites W3026923587 @default.
• W2103246276 cites W2170589119 @default.
• W2103246276 doi "https://doi.org/10.2147/rru.s5004" @default.
• W2103246276 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3806400" @default.
• W2103246276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24198606" @default.
• W2103246276 hasPublicationYear "2009" @default.
• W2103246276 type Work @default.
• W2103246276 sameAs 2103246276 @default.
• W2103246276 citedByCount "3" @default.
• W2103246276 countsByYear W21032462762015 @default.
• W2103246276 countsByYear W21032462762023 @default.
• W2103246276 crossrefType "journal-article" @default.
• W2103246276 hasAuthorship W2103246276A5000874948 @default.
• W2103246276 hasAuthorship W2103246276A5005428468 @default.
• W2103246276 hasAuthorship W2103246276A5049505360 @default.
• W2103246276 hasAuthorship W2103246276A5061041464 @default.
• W2103246276 hasAuthorship W2103246276A5077854199 @default.
• W2103246276 hasAuthorship W2103246276A5083613523 @default.
• W2103246276 hasBestOaLocation W21032462761 @default.
• W2103246276 hasConcept C121608353 @default.
• W2103246276 hasConcept C126322002 @default.
• W2103246276 hasConcept C126894567 @default.

• next